Augmenting the efficacy of anti-cocaine catalytic antibodies through chimeric hapten design and combinatorial vaccination

Bioorg Med Chem Lett. 2017 Aug 15;27(16):3666-3668. doi: 10.1016/j.bmcl.2017.07.014. Epub 2017 Jul 5.

Abstract

Given the need for further improvements in anti-cocaine vaccination strategies, a chimeric hapten (GNET) was developed that combines chemically-stable structural features from steady-state haptens with the hydrolytic functionality present in transition-state mimetic haptens. Additionally, as a further investigation into the generation of an improved bifunctional antibody pool, sequential vaccination with steady-state and transition-state mimetic haptens was undertaken. While GNET induced the formation of catalytically-active antibodies, it did not improve overall behavioral efficacy. In contrast, the resulting pool of antibodies from GNE/GNT co-administration demonstrated intermediate efficacy as compared to antibodies developed from either hapten alone. Overall, improved antibody catalytic efficiency appears necessary to achieve the synergistic benefits of combining cocaine hydrolysis with peripheral sequestration.

Keywords: Addiction; Catalytic antibody; Chimeric hapten; Cocaine; Vaccine.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Animals
  • Antibodies, Catalytic / blood
  • Antibodies, Catalytic / immunology*
  • Antibodies, Catalytic / metabolism
  • Catalysis
  • Cocaine / chemistry
  • Cocaine / immunology*
  • Cocaine / pharmacology
  • Enzyme-Linked Immunosorbent Assay
  • Haptens / chemistry
  • Haptens / immunology*
  • Immunoglobulin G / blood
  • Locomotion / drug effects
  • Radioimmunoassay
  • Vaccination

Substances

  • Antibodies, Catalytic
  • Haptens
  • Immunoglobulin G
  • Cocaine